Davis Aaron I.'s Form 4 filing
iTeos Therapeutics, Inc. (ITOS) · filed Mar 24, 2022
- Accession no.
- 0000899243-22-012152
- Filed
- Mar 24, 2022
- Trade date
- Mar 22-23, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market purchases total $1.63M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Davis Aaron I.CIK 0001465914 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 22, 2022 | Common Stock | PPurchaseAcquired | +21,300 | $31.88 | +$679,044 | 3,163,358 | Indirect | |
| Mar 22, 2022 | Common Stock | PPurchaseAcquired | +3,700 | $33.09 | +$122,433 | 3,167,058 | Indirect | |
| Mar 22, 2022 | Common Stock | PPurchaseAcquired | +5,000 | $33.43 | +$167,150 | 3,172,058 | Indirect | |
| Mar 23, 2022 | Common Stock | PPurchaseAcquired | +20,000 | $32.85 | +$657,000 | 3,192,058 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.